Prediction of Version Outcomes for External Maneuvers of Breech Fetus by Assessment of Breech Progression Angle

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

Breech presentation complicates about 3-4% of single pregnancies at term. Although vaginal delivery is also possible in breech presentations, this is associated with an increased risk of fetal morbidity and mortality. The cephalic version for external maneuvers is an obstetric procedure that allows conversion of an abnormal presentation/situation (breech or transverse) to a cephalic presentation by applying pressure to the maternal abdomen. Over the years, many authors have analyzed numerous factors that might be associated with an increased likelihood of successful maneuvering. Over time, transperineal ultrasonography has proven to be a valid, objective, and highly reproducible tool for the assessment of fetal head progression during delivery in conjunction with examination. The Angle of Progression (AoP) is the angle between the line passing through the longitudinal axis of the pubic symphysis and the line passing through the inferior border of the pubic symphysis and tangent to the fetal skull. AoP is an accurate and reproducible parameter for the assessment of fetal head descent during labor, with a strong correlation with the mode of delivery. The investigators are not aware of any studies that have established the role of transperineal ultrasound in assessing podietal engagement and its role in predicting the success of the cephalic version maneuver, an aspect the investigators want to explore with this study.

Eligibility criteria

Qualifiers

Women >18 years of age with a single pregnancy at term (37-42 gestational weeks) with a fetus in breech presentation

Acquisition of Informed Consent Form

Disqualifiers

Oligohydramnios: maximum flap < 2cm

Placenta previa

Uterine malformations

Regular uterine dynamics

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed